Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
LRTOMT includes two transcript forms. Additionally we are shipping Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing Antibodies (8) and many more products for this protein.
Showing 7 out of 7 products:
LRTOMT gene is the second cause of congenital hearing impairment in Moroccan patients.
A 1 bp deletion in the dual reading frame deafness gene LRTOMT causes a frameshift from the first into the second reading frame.
A genome wide linkage analysis of nonsyndromic deafness segregating in a consanguineous Pakistani family (PKDF537) was used to identify DFNB63, a new locus for congenital profound sensorineural hearing loss.
Mutations of LRTOMT are associated with profound nonsyndromic hearing loss at the DFNB63 locus on human chromosome 11q13.3-q13.4.
This gene includes two transcript forms. The short form has one open reading frame (ORF), which encodes the leucine-rich repeats (LRR)-containing protein of unknown function. This protein is called LRTOMT1 or LRRC51. The long form has two alternative ORFs\; the upstream ORF has the same translation start codon as used in the short form and the resulting transcript is a candidate for nonsense-mediated decay, and the downstream ORF encodes a different protein, which is a transmembrane catechol-O-methyltransferase and is called LRTOMT2, TOMT or COMT2. The COMT2 is essential for auditory and vestibular function. Defects in the COMT2 can cause nonsyndromic deafness. Alternatively spliced transcript variants from each transcript form have been found for this gene.
leucine-rich repeat-containing protein 51
, leucine rich transmembrane and 0-methyltransferase domain containing
, transmembrane O-methyltransferase
, leucine rich repeat containing 51
, catechol O-methyltransferase 2
, leucine rich transmembrane and O-methyltransferase domain containing
, catechol-O-methyltransferase 2